Inactivity of terbinafine in a rat model of pulmonary aspergillosis
- 1 November 1990
- journal article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 9 (11) , 832-835
- https://doi.org/10.1007/bf01967386
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Pharmacokinetics of aerosol amphotericin B in ratsAntimicrobial Agents and Chemotherapy, 1990
- Aerosol amphotericin B is effective for prophylaxis and therapy in a rat model of pulmonary aspergillosisAntimicrobial Agents and Chemotherapy, 1988
- An approach to intensive antileukemia therapy in patients with previous invasive aspergillosisThe American Journal of Medicine, 1988
- MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus sppAntimicrobial Agents and Chemotherapy, 1988
- Activity of terbinafine in experimental fungal infections of laboratory animalsAntimicrobial Agents and Chemotherapy, 1987
- Antifungal activity of the allylamine derivative terbinafine in vitroAntimicrobial Agents and Chemotherapy, 1987
- Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymesBiochemical Journal, 1985
- In-vitro studies with SF 86–327, a new orally active allylamine derivativeMedical Mycology, 1985
- Synthesis and antifungal activity of (E)-N-(6,6-dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethanamine (SF 86-327) and related allylamine derivatives with enhanced oral activityJournal of Medicinal Chemistry, 1984
- Effect of the antimycotic drug naftifine on growth of and sterol biosynthesis in Candida albicansAntimicrobial Agents and Chemotherapy, 1984